A Global Phase 2 Study of Valemetostat Tosylate (Valemetostat) in Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL), Including R/R Adult T-Cell Leukemia/Lymphoma (ATL) - Valentine-PTCL01

Francine M Foss,Pierluigi Porcu,Steven M Horwitz,Koji Izutsu,Kenji Ishitsuka,Kazunobu Kato,Jin Jin,Yining Du,Ai Inoue

doi:10.1182/blood-2021-144676

A Global Phase 2 Study of Valemetostat Tosylate (Valemetostat) in Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL), Including R/R Adult T-Cell Leukemia/Lymphoma (ATL) - Valentine-PTCL01

Francine M Foss, Pierluigi Porcu + Show 7 more

Open Access

https://doi.org/10.1182/blood-2021-144676

Copy DOI

Journal: Blood	Publication Date: Nov 5, 2021
Citations: 11

Affiliation: Yale University, Thomas Jefferson University, Memorial Sloan Kettering Cancer Center, Tokyo National Hospital, Kagoshima University Hospital, Daiichi Sankyo (United States)

#Research Funding #Daiichi Sankyo + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

A Global Phase 2 Study of Valemetostat Tosylate (Valemetostat) in Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL), Including R/R Adult T-Cell Leukemia/Lymphoma (ATL) - Valentine-PTCL01

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.